125 related articles for article (PubMed ID: 38031224)
1. COVID-19 vaccine safety and side effects in children aged 5-11 years: a cross-sectional study.
Nurhani MA; Farah HMS; Ili NMA; Zahidah AR; Rahimah B; Nabilah HK; Gan LL; David NCE
Med J Malaysia; 2023 Nov; 78(6):803-807. PubMed ID: 38031224
[TBL] [Abstract][Full Text] [Related]
2. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community.
Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A
BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613
[TBL] [Abstract][Full Text] [Related]
3. Reactions following Pfizer-BioNTech COVID-19 mRNA vaccination and related healthcare encounters among 7,077 children aged 5-11 years within an integrated healthcare system.
Malden DE; Gee J; Glenn S; Li Z; Mercado C; Ogun OA; Kim S; Lewin BJ; Ackerson BK; Jazwa A; Weintraub ES; McNeil MM; Tartof SY
Vaccine; 2023 Jan; 41(2):315-322. PubMed ID: 36351861
[TBL] [Abstract][Full Text] [Related]
4. Adverse events following BNT162b2 mRNA COVID-19 vaccination among healthcare workers: A single-centre experience in Malaysia.
Gan LL; Zahidah AR; Hazirah T; Nabilah HK; Aisyah Z; Amin INM; Ng DCE
Med J Malaysia; 2022 May; 77(3):300-305. PubMed ID: 35638485
[TBL] [Abstract][Full Text] [Related]
5. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.
Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M
Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030
[TBL] [Abstract][Full Text] [Related]
6. A retrospective evaluation of side-effects associated with the booster dose of Pfizer-BioNTech/BNT162b2 COVID-19 vaccine among females in Eastern Province, Saudi Arabia.
Hassan YAM; Daud Ali M; Al-Eid RR; Al-Ghuraya FA; Essa Alqasimi Z; Ahmad A; Eltrafi Z; Ghosn SA
Vaccine; 2022 Nov; 40(49):7087-7096. PubMed ID: 36404426
[TBL] [Abstract][Full Text] [Related]
7. Short term safety of BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine among children aged 5-11 years, a nationwide parental survey.
Shapiro Ben David S; Baruch Gez S; Adler L; Kovatch R; Rahamim-Cohen D; Shamir-Stein N; Shahar A; Mizrhi-Reuveni M
Vaccine; 2024 Feb; 42(5):1154-1159. PubMed ID: 38281902
[TBL] [Abstract][Full Text] [Related]
8. Adverse events following immunisation of COVID-19 vaccine among health care workers in the first phase of vaccination.
Rahmat H; Leelavathi M; Wan Ismail WF
Med J Malaysia; 2022 Nov; 77(6):637-642. PubMed ID: 36448378
[TBL] [Abstract][Full Text] [Related]
9. Safety and effectiveness of vaccines against COVID-19 in children aged 5-11 years: a systematic review and meta-analysis.
Piechotta V; Siemens W; Thielemann I; Toews M; Koch J; Vygen-Bonnet S; Kothari K; Grummich K; Braun C; Kapp P; Labonté V; Wichmann O; Meerpohl JJ; Harder T
Lancet Child Adolesc Health; 2023 Jun; 7(6):379-391. PubMed ID: 37084750
[TBL] [Abstract][Full Text] [Related]
10. Safety, effectiveness and hesitancy of COVID-19 vaccination in children: A cross-sectional study in Pakistan.
Zaufishan Z; Usman M; Fishan Mumtaz K; Bilal R; Arshad A; Khan HM
Front Public Health; 2022; 10():1084017. PubMed ID: 36733278
[TBL] [Abstract][Full Text] [Related]
11. Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children.
Dionne A; Sperotto F; Chamberlain S; Baker AL; Powell AJ; Prakash A; Castellanos DA; Saleeb SF; de Ferranti SD; Newburger JW; Friedman KG
JAMA Cardiol; 2021 Dec; 6(12):1446-1450. PubMed ID: 34374740
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021.
Hause AM; Baggs J; Marquez P; Myers TR; Gee J; Su JR; Zhang B; Thompson D; Shimabukuro TT; Shay DK
MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(5152):1755-1760. PubMed ID: 34968370
[TBL] [Abstract][Full Text] [Related]
13. The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.
Deng L; Glover C; Dymock M; Pillsbury A; Marsh JA; Quinn HE; Leeb A; Cashman P; Snelling TL; Wood N; Macartney K
Med J Aust; 2022 Aug; 217(4):195-202. PubMed ID: 35781813
[TBL] [Abstract][Full Text] [Related]
14. Covid-19 vaccination reported side effects and hesitancy among the Syrian population: a cross-sectional study.
Najjar M; Albuaini S; Fadel M; Mohsen F; ; Najjar G; Assaf D; Aljbawi A; AlAwad Y
Ann Med; 2023; 55(2):2241351. PubMed ID: 37544017
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 vaccination side effects among the child age group: a large cross-sectional online based survey in Saudi Arabia.
Alwafi H; Naser AY; Aldhahir AM; Alhazmi A; Alosaimi AN; Mandili RA; Majeed Z; Salawati E; Ekram R; Samannodi M; Assaggaf H; Almatrafi M; Alqahtani JS; Alsanosi SM; Minshawi F
BMC Infect Dis; 2022 Dec; 22(1):911. PubMed ID: 36474174
[TBL] [Abstract][Full Text] [Related]
16. Early experience of COVID-19 vaccine-related adverse events among adolescents and young adults with rheumatic diseases: A single-center study.
Haslak F; Gunalp A; Cebi MN; Yildiz M; Adrovic A; Sahin S; Barut K; Kasapcopur O
Int J Rheum Dis; 2022 Mar; 25(3):353-363. PubMed ID: 34978376
[TBL] [Abstract][Full Text] [Related]
17. Examination of Adverse Reactions After COVID-19 Vaccination Among Patients With a History of Multisystem Inflammatory Syndrome in Children.
Elias MD; Truong DT; Oster ME; Trachtenberg FL; Mu X; Jone PN; Mitchell EC; Dummer KB; Sexson Tejtel SK; Osakwe O; Thacker D; Su JA; Bradford TT; Burns KM; Campbell MJ; Connors TJ; D'Addese L; Forsha D; Frosch OH; Giglia TM; Goodell LR; Handler SS; Hasbani K; Hebson C; Krishnan A; Lang SM; McCrindle BW; McHugh KE; Morgan LM; Payne RM; Sabati A; Sagiv E; Sanil Y; Serrano F; Newburger JW; Dionne A;
JAMA Netw Open; 2023 Jan; 6(1):e2248987. PubMed ID: 36595296
[TBL] [Abstract][Full Text] [Related]
18. Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12-18 Years in Saudi Arabia.
Alamer E; Alhazmi A; Qasir NA; Alamer R; Areeshi H; Gohal G; Qadri M; Hashem AM; Algaissi A
Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835228
[No Abstract] [Full Text] [Related]
19. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK
PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759
[TBL] [Abstract][Full Text] [Related]
20. Evaluate the side effect associated with COVID-19 vaccine on adolescents in Riyadh, Saudi Arabia: A cross-section study.
Aldali JA; Alotaibi FT; Alasiri GA; Almesned RA; Alromih AM; Almohandes AM; Alsenidi SF
Saudi Med J; 2022 Nov; 43(11):1248-1253. PubMed ID: 36379531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
